Home / Healthcare / Global Artificial Intelligence (AI) in Drug Discovery Market Research Report (2019-2026)
Report Image

Global Artificial Intelligence (AI) in Drug Discovery Market Research Report (2019-2026)

ID:MR2393 | May-2020 | Global | 137 Pages

COVID-19

Get in-depth analysis of the COVID-19 impact on this Market

At 31.7% CAGR, Artificial Intelligence in Drug Discovery Market Size is Expected to Exhibit 2.01 billion USD by 2026, according to the analysis of MarketandReport.

Scope of the Report:

The detailed market intelligence report on the Global Artificial Intelligence in Drug Discovery Market Covers the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Artificial Intelligence in Drug Discovery Market place for the forecast 2019-2026.

The Major Players are covered:

IBM Corporation (US)

Microsoft (US)

Google (US)

NVIDIA Corporation (US)

Atomwise, Inc. (US)

Exscientia (UK)

Cyclica (Canada)

BIOAGE (US)

Numerate (US)

Numedii (US)

Envisagenics (US)

twoXAR (US),

OWKIN, Inc. (US)

XtalPi (US)

Verge Genomics (US)

Berg LLC (US)

Deep Genomics (Canada)

Cloud Pharmaceuticals (US)

Insilico Medicine (US)

Benevolent AI (UK)

On the basis of offering, the artificial intelligence in drug discovery market is segmented into software and services. The services segment is expected to grow at the highest CAGR during the forecast period. AI is a complex method as it requires the implementation of sophisticated algorithms for a wide range of applications in drug discovery, precision medicine, medical imaging and diagnostics, and patient data and risk analysis, among others. Hence, for the successful implementation of AI, there is a need for deployment & integration and support & maintenance services. These are some of the major factors responsible for the high growth rate of this segment

On the basis of technology, the artificial intelligence in drug discovery market is segmented into machine learning and other technologies (context-aware computing and natural language processing). The machine learning segment dominated this market in 2018 as pharmaceutical companies, CROs, and biotechnology companies have widely adopted machine learning for drug discovery applications. This is because machine learning has the capability to extract insights from data sets, which helps accelerate the drug discovery process.

In 2018, North America was the largest and the fastest growing regional market for AI in drug discovery. North America, which comprises the US, Canada, and Mexico, forms the largest market for AI in drug discovery. These countries have been early adopters of AI technology in drug discovery and development. In the North American market, the US is a major contributor. In addition, prominent AI technology providers, such as IBM, Google, Microsoft, NVIDIA, and Intel are headquartered in the US; their strong presence is a key contributor to market growth. Other drivers include the well-established pharmaceutical industry, high focus on R&D & substantial investment, and the presence of globally leading pharmaceutical companies. These are some of the major factors responsible for the large share and high growth rate of this market.

IBM Corporation (US): IBM is among the leading companies in the AI in the drug discovery market. End-users widely use the company's Watson for cognitive computing and data-driven applications. IBM follows organic as well as inorganic growth strategies to improve its position in the AI in drug discovery and other emerging AI markets.

Artificial Intelligence in Drug Discovery Market Segmentation:

By Drug by Offering

Software

Services

By Technology

Machine Learning

Deep Learning

Supervised Learning

Reinforcement Learning

Unsupervised Learning

Other Machine Learning Technologies

Others Technologies

By Therapeutic Type

Metabolic Disease
Cardiovascular Disease
Oncology
Neurodegenerative Diseases
Others

By Application

Immuno-oncology

Neurodegenerative Diseases

Cardiovascular Diseases

Metabolic Diseases

Others

By End-Users
Pharmaceutical Companies
Biopharmaceutical Companies
Academic and Research Institutes
Others

By Geography

North America

Europe

Asia-Pacific

ROW


  Single user                       $ 1690.00
  Corporate-User                $ 3690.00

PERSONALIZE THIS RESEARCH

  • Any level of Personalization
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Get Data as per your Format and Definition
  • Triangulate with your Own Data